Tuesday, September 20, 2016

Medicare EpiPen spending outpaces prescription growth -Kaiser report

NEW YORK, Sept 20 (Reuters) - U.S. government spending on

Mylan Inc's EpiPen in the Medicare program for seniors

and the disabled rose 1,151 percent from 2007 through 2014,

while the number of EpiPen...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)